GLG Partners LP Lowers Stake in Humana Inc. (HUM)
GLG Partners LP cut its holdings in Humana Inc. (NYSE:HUM) by 50.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,707 shares of the insurance provider’s stock after selling 11,110 shares during the quarter. GLG Partners LP’s holdings in Humana were worth $2,576,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the company. Acrospire Investment Management LLC purchased a new stake in Humana during the 2nd quarter worth about $120,000. Independent Portfolio Consultants Inc. raised its stake in Humana by 22.1% in the 2nd quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after purchasing an additional 94 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Humana by 139.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after purchasing an additional 325 shares during the last quarter. Fiduciary Trust Co. acquired a new position in Humana in the 2nd quarter valued at about $135,000. Finally, Guardian Life Insurance Co. of America raised its stake in Humana by 0.7% in the 1st quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 4 shares during the last quarter. Institutional investors and hedge funds own 95.12% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “GLG Partners LP Lowers Stake in Humana Inc. (HUM)” was first reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.watchlistnews.com/glg-partners-lp-lowers-stake-in-humana-inc-hum/1605499.html.
A number of research analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Humana from a “hold” rating to a “buy” rating and set a $255.00 target price on the stock in a report on Tuesday, June 13th. BidaskClub downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, June 13th. Citigroup Inc. started coverage on shares of Humana in a report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price target for the company. Credit Suisse Group reissued an “outperform” rating and issued a $260.00 price objective (up previously from $250.00) on shares of Humana in a research report on Thursday, August 3rd. Finally, Deutsche Bank AG boosted their price objective on shares of Humana from $234.00 to $243.00 and gave the company a “hold” rating in a research report on Monday, August 7th. Nine investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. Humana currently has a consensus rating of “Buy” and a consensus target price of $247.50.
Humana Inc. (HUM) traded up 0.48% during trading on Tuesday, hitting $246.17. 172,155 shares of the company traded hands. The firm has a 50 day moving average of $249.26 and a 200 day moving average of $233.71. The firm has a market cap of $35.58 billion, a P/E ratio of 20.25 and a beta of 0.86. Humana Inc. has a one year low of $163.50 and a one year high of $259.76.
Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.08 by $0.41. Humana had a return on equity of 15.85% and a net margin of 3.37%. The firm had revenue of $13.53 billion for the quarter, compared to the consensus estimate of $13.61 billion. During the same quarter in the prior year, the company posted $2.30 earnings per share. On average, analysts expect that Humana Inc. will post $11.55 earnings per share for the current fiscal year.
The firm also recently announced a dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s dividend payout ratio (DPR) is presently 13.06%.
In other news, VP Timothy S. Huval sold 7,803 shares of the stock in a transaction on Friday, September 1st. The shares were sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the transaction, the vice president now owns 8,831 shares in the company, valued at approximately $2,279,634.34. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of the firm’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the transaction, the insider now owns 18,042 shares in the company, valued at approximately $4,672,878. The disclosure for this sale can be found here. Insiders sold 55,595 shares of company stock valued at $14,133,706 over the last quarter. Corporate insiders own 0.80% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.